Patents by Inventor Kathryn J. Chavez

Kathryn J. Chavez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150073045
    Abstract: The invention relates to a novel compound of the formula or pharmaceutically acceptable salts thereof as well as pharmaceutical, nutraceutical, and botanical drug compositions and therapeutic methods related thereto. In certain embodiments, the compounds are used for the treatment of abnormal cell growth, hyperproliferative disorders, and inflammatory diseases in mammals. In other embodiments, the invention encompasses methods to isolate and synthesize the compounds.
    Type: Application
    Filed: November 17, 2014
    Publication date: March 12, 2015
    Applicant: CORNELL UNIVERSITY
    Inventors: Kathryn J. Chavez, Eloy Rodriguez, Frank Schroeder, James A. Flanders
  • Publication number: 20140128458
    Abstract: The invention relates to a novel compound of the formula or pharmaceutically acceptable salts thereof as well as pharmaceutical, nutraceutical, and botanical drug compositions and therapeutic methods related thereto. In certain embodiments, the compounds are used for the treatment of abnormal cell growth, hyperproliferative disorders, and inflammatory diseases in mammals. In other embodiments, the invention encompasses methods to isolate and synthesize the compounds.
    Type: Application
    Filed: October 1, 2013
    Publication date: May 8, 2014
    Applicant: CORNELL UNIVERSITY
    Inventors: Kathryn J. Chavez, Eloy Rodriguez, Frank Schroeder, James A. Flanders
  • Patent number: 8563603
    Abstract: The invention relates to a novel compound of formula I or pharmaceutically acceptable salts thereof as well as pharmaceutical, nutraceutical, and botanical drug compositions and therapeutic methods related thereto. In certain embodiments, the compounds are used for the treatment of abnormal cell growth, hyperproliferative disorders, and inflammatory diseases in mammals. In other embodiments, the invention encompasses methods to isolate and synthesize the compounds.
    Type: Grant
    Filed: October 22, 2009
    Date of Patent: October 22, 2013
    Assignee: Cornell University
    Inventors: Kathryn J. Chavez, Eloy Rodriguez, Frank Schroeder, James A. Flanders
  • Publication number: 20110275708
    Abstract: The invention relates to a novel compound of formula I or pharmaceutically acceptable salts thereof as well as pharmaceutical, nutraceutical, and botanical drug compositions and therapeutic methods related thereto. In certain embodiments, the compounds are used for the treatment of abnormal cell growth, hyperproliferative disorders, and inflammatory diseases in mammals. In other embodiments, the invention encompasses methods to isolate and synthesize the compounds.
    Type: Application
    Filed: October 22, 2009
    Publication date: November 10, 2011
    Applicant: CORNELL UNIVERSITY
    Inventors: Kathryn J. Chavez, Eloy Rodriguez, Frank Schroeder, James A. Flanders